CANVAS | Enhancing Cancer Vaccine Science for New Therapy Pathways

Summary
The main objective of the project Enhancing Cancer Vaccine Science for New Therapy Pathways (CANVAS) is to significantly raise the scientific profile, networking, and research management competencies at the International Centre for Cancer Vaccine Science (ICCVS) at the University of Gdańsk (UG), Poland, to achieve improved research excellence in cancer vaccine science. The project aims to contribute to reduction of the disparities in R&I in Europe by networking activities with outstanding leading European research partners: University of Rome Tor Vergata (UNITOV), Italy, and Alternative Energies and Atomic Energy Commission (CEA), France. The partnership includes also a biotech start-up Real Research (Poland), to foster intersectoral knowledge transfer for innovative translational research approaches. A strong focus on upgrade of grant writing and research management skills will improve long-term competitiveness in obtaining funding. In addition a joint pilot study is planned in the project. We expect that it will provide the foundation for a novel patient tailored therapy of non-small cell lung cancer. Thus, apart from the scientific impact, in the long term innovations generated with the support of the CANVAS partnership have a translational potential to contribute to improving therapy for cancer patients, which give the project a pivotal economic and societal impact.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101079510
Start date: 01-10-2022
End date: 30-09-2025
Total budget - Public funding: 1 499 512,50 Euro - 1 499 512,00 Euro
Cordis data

Original description

The main objective of the project Enhancing Cancer Vaccine Science for New Therapy Pathways (CANVAS) is to significantly raise the scientific profile, networking, and research management competencies at the International Centre for Cancer Vaccine Science (ICCVS) at the University of Gdańsk (UG), Poland, to achieve improved research excellence in cancer vaccine science. The project aims to contribute to reduction of the disparities in R&I in Europe by networking activities with outstanding leading European research partners: University of Rome Tor Vergata (UNITOV), Italy, and Alternative Energies and Atomic Energy Commission (CEA), France. The partnership includes also a biotech start-up Real Research (Poland), to foster intersectoral knowledge transfer for innovative translational research approaches. A strong focus on upgrade of grant writing and research management skills will improve long-term competitiveness in obtaining funding. In addition a joint pilot study is planned in the project. We expect that it will provide the foundation for a novel patient tailored therapy of non-small cell lung cancer. Thus, apart from the scientific impact, in the long term innovations generated with the support of the CANVAS partnership have a translational potential to contribute to improving therapy for cancer patients, which give the project a pivotal economic and societal impact.

Status

SIGNED

Call topic

HORIZON-WIDERA-2021-ACCESS-03-01

Update Date

09-02-2023
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.4 Widening Participation and Strengthening the European Research Area
HORIZON.4.1 Widening participation and spreading excellence
HORIZON.4.1.2 Twinning
HORIZON-WIDERA-2021-ACCESS-03
HORIZON-WIDERA-2021-ACCESS-03-01 Twinning